Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (U01 AI142756)
National Human Genome Research Institute (RM1 HG009490)
National Institute of Biomedical Imaging and Bioengineering (R01 EB022376)
National Institute of General Medical Sciences (R35 GM118062)
Defense Advanced Research Projects Agency (HR0011-17-2-0049)
Howard Hughes Medical Institute (Liu Investigatorship)
Received: 21 December 2018
Accepted: 14 June 2019
First Online: 22 July 2019
Change Date: 12 August 2019
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
: D.R.L. is a consultant and co-founder of Beam Therapeutics, Editas Medicine and Pairwise Plants, companies that use genome editing. D.R.L., B.W.T. and C.W. have filed patent applications on aspects of this work.